Healthcare Data & Analytics / SaaS / Healthcare Technology
Strategic Profile
The company positions itself as an industry leader in healthcare market data and analytics with differentiated data assets, AI analytics capabilities, and integration partnerships. Despite current profitability challenges and revenue pressures (2026 guidance projects $220-226M, down from $241.5M in 2025), management emphasizes strategic investments in data infrastructure, customer success initiatives, and retention to support long-term margin expansion and market share gains.
Cyborg Score Rationale
Definitive Healthcare demonstrates solid market positioning in healthcare intelligence with strong data assets, high customer value, and solid adjusted EBITDA margins (29% in 2025). However, the company faces significant headwinds including declining revenue guidance for 2026, a major goodwill impairment ($196.1M in 2025), current unprofitability, and compressed margins due to intensifying competition from AI tools and restricted customer IT budgets.
Top Insights
2025 full-year revenue of $241.5M with adjusted EBITDA of $70.4M (29% margin) and $54.9M unlevered free cash flow demonstrates underlying business strength despite profitability challenges
2026 guidance shows revenue decline to $220-226M and EBITDA compression to $53-58M, reflecting customer budget pressures and competitive intensity in the healthcare data space
Company recorded substantial $196.1M goodwill impairment in 2025, signaling past acquisition missteps and potential valuation concerns that may persist
Management execution focus on enhancing data differentiation, customer retention initiatives, and digital partnerships represents strategic pivot but must overcome commodity AI competition and data privacy regulatory headwinds
Named Competitors
Healthcare Workforce Management — Healthcare IT training and workforce analytics
Clinical Data Analytics — Healthcare data analytics and insights platform
Pharma/Biotech Analytics — Pharma and biotech modeling and analytics